Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer.
D000276:Adjuvants, Immunologic / Q000652:urine; D014408:Biomarkers, Tumor / Q000652:urine*; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis / Q000652:urine*; D015853:Cysteine Proteinase Inhibitors / Q000652:urine; D003558:Cystoscopy; D053222:Fas Ligand Protein / Q000652:urine; D006801:Humans; D006820:Hyaluronic Acid / Q000652:urine; D006821:Hyaluronoglucosaminidase / Q000652:urine; D017404:In Situ Hybridization, Fluorescence; D051034:Inhibitor of Apoptosis Proteins; D016256:Lewis X Antigen / Q000652:urine; D008869:Microtubule-Associated Proteins / Q000652:urine; D009687:Nuclear Proteins / Q000652:urine; D011159:Population Surveillance / Q000379:methods*; D011379:Prognosis; D012680:Sensitivity and Specificity; D000077022:Survivin; D019098:Telomerase / Q000652:urine; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000652:urine*; D009363:Neoplasm Proteins
D000276:Adjuvants, Immunologic; D014408:Biomarkers, Tumor; D015853:Cysteine Proteinase Inhibitors; D053222:Fas Ligand Protein; D006820:Hyaluronic Acid; D006821:Hyaluronoglucosaminidase; D051034:Inhibitor of Apoptosis Proteins; D016256:Lewis X Antigen; D008869:Microtubule-Associated Proteins; D009687:Nuclear Proteins; D000077022:Survivin; D019098:Telomerase; C107489:BIRC5 protein, human; C413062:BLCA-4 protein, human; D009363:Neoplasm Proteins; C100379:nuclear matrix protein 22